Israel Active

Israeli NGO ZAKA, plans to open resilience centers around Israel. They will provide healing therapies to first responders as well as cater to Israelis who are struggling with mental health. ZAKA’s 3,000 volunteers provide the most holy of services - recovering bodies at scenes of tragedies.

More information about the GlP-1 Edge treatment from Israel’s Lembas (see previously).

Days after their labs were devastated by an Iranian missile, researchers at Weizmann Institute published findings that could lead to a blood test for detecting a person’s risk of developing leukemia. The test might also replace the invasive diagnostic procedure of bone marrow sampling.

United States Ambassador to Israel Mike Huckabee and his wife, Janet, donated blood following a visit to Magen David Adom’s (MDA) National Headquarters in Ramla. On his tour he saw MDA’s advanced in-house-developed technologies and met with emergency teams.

Georgetown University in the US is home to the federally-designated Lombardi Comprehensive Cancer Center. Its joint initiative with the Hebrew University of Jerusalem is expected to accelerate progress toward more effective cancer prevention, diagnosis, and treatment.

A rare mutation in the GRIN2D gene causes seizures in only 40 people worldwide. Yet Tel Aviv University researchers have developed a mouse model to replicate the condition, allowing scientists to work towards pharmacological and gene-based therapeutic strategies.

Israel’s OSSIO recently expanded its best-in-class soft-tissue fixation portfolio with the launch of OSSIOfiber® 2.5mm Suture Anchors, which promise to improve several surgical procedures, including Brostrom repair for lateral ankle instability.

A 16-year-old girl from northern Israel turned to ChatGPT for advice upon discovering a mysterious lump in her abdomen. After a series of follow-up questions, the AI chatbot recommended blood tests and an ultrasound. Subsequent surgery removed a large mass from her pancreas.

Researchers at Israel’s Ben-Gurion University have discovered molecules in corals that prevent bacteria from making the biofilm that connects them. This disrupts their communication, weakening infections and enhancing antibiotic effectiveness without harming beneficial microbiota.

Israel’s BrainsWay reported success in the trial of its accelerated Deep TMS protocol on 104 patients suffering from Major Depressive Disorder (MDD). Both programs of accelerated (10mins) and standard (20 mins) treatment sessions had very high response rates, remission rates, and time to remission.